The Single Ground Station of International Scientific Research (scientific research on a single ground complex) is organized jointly by the Institute of the Russian State Scientific Center for Biomedical Problems of the Russian Academy of Sciences in cooperation with partner organizations with the wide participation of specialists from Russia and other countries.
The essence of the project is the implementation of several stages of long-term tests that simulate human flight into space with the performance of various missions in virtual reality mode and in complete isolation. Subjects will be in a unique land complex without the opportunity to leave the place – it’s all real!
The main objective of the experiment, according to the project’s press service, is to test innovative methods for diagnosing possible expected and unforeseen adverse factors that may arise during a real interplanetary flight. The second task is the preparation of new experiments on board, the use of equipment and equipment by the crew, including in VR mode.
An important task to ensure crew safety is completing a first aid kit. Therefore, scientists have identified the most important medications to fill the first aid kits that astronauts may need to simulate interplanetary travel and that will be available on board.
In conditions of isolation and weightlessness, a series of specific health problems can arise. In particular, changes in physical activity, daily routine, new diet, stress and overload are factors that can destabilize the digestive, nervous and other systems of the human body.
The cosmonauts’ first aid kit included the enterosorbent Enterosgel. The choice in favor of this drug was due to its high effectiveness and ready-to-use release form. The first aid kit also included antipyretics, pain relievers, antihistamines and other essential medications. The specialists who were involved in the selection of medicines for the crew tried to provide a first aid kit “for all occasions”, taking into account the conditions of the upcoming experiment. Doctor of aeronautical and space medicine Ksenia Dmitrievna Orlova (Russia), who already participated in the SIRIUS-21 isolation experiment, will monitor the health and well-being of participants in scientific research. The experience gained by the on-board doctor and optimally selected medications will help minimize health risks to the crew on the next research mission.
